Esmethadone Shows Promise as Adjunctive Treatment for Antidepressant Tolerance
HCP Live,
A post-hoc analysis of a phase 3 trial showed the potential of esmethadone (REL-1017) as an adjunctive treatment for patients…
Esmethadone (REL-1017) in Patients With Major Depressive Disorder and Antidepressant Tachyphylaxis: An Exploratory Post Hoc Analysis From a Phase 3 Randomized Controlled Trial.
Overview of attention for article published in Journal of Clinical Psychiatry, October 2025
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (91st percentile)
-
Good Attention Score compared to outputs of the same age and source (70th percentile)
Readers on
- mendeley
- 3 Mendeley
